Author

Sophia Lisette Maund

Observed names: Maund, Sophia, Maund, Sophia L., Maund, Sophia Lisette, S. L. Maund, S. Maund, S.L. Maund, Sophia L Maund, Sophia L. Maund, Sophia L. Maund¤a, Sophia Maund

Institution: Genentech

Observed institutions: Genentech, Purdue University West Lafayette, United States Army Medical Research and Development Command, University of Colorado Health, Stanford Medicine, Wake Forest University Health Sciences, Wake Forest University, University of Colorado Anschutz, Stanford University

ORCID: 0000-0002-6992-2914

Observed ORCID: 0000-0002-6992-2914

OpenAlex ID: A5048914713

A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples

2019 · Sally E. Trabucco, Kyle Gowen, et al. · Journal of Molecular Diagnostics · 223

PDF

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

2021 · C. B. Westphalen, M. G. Krebs, et al. · npj Precision Oncology · 207

PDF

Molecular determinants of response to PD-L1 blockade across tumor types

2021 · Romain Banchereau, Ning Leng, et al. · Nature Communications · 164

PDF

Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients

2020 · Tharu M. Fernando, Robert Piskol, et al. · Nature Communications · 155

PDF

Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy

2013 · Brian Belardi, Adam de la Zerda, et al. · Angewandte Chemie International Edition · 100

PDF

Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics

2017 · David R. Spiciarich, Rosalie Nolley, et al. · Angewandte Chemie International Edition · 73

Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells

2011 · Sophia L. Maund, Wendy W. Barclay, et al. · Cancer Research · 62

PDF

Characterization of Adult Prostatic Progenitor/Stem Cells Exhibiting Self-Renewal and Multilineage Differentiation

2007 · Wendy W. Barclay, Linara S. Axanova, et al. · Stem Cells · 62

PDF

Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade

2024 · Habib Hamidi, Yasin Senbabaoglu, et al. · Cancer Cell · 56

Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate

2013 · Sophia Lisette Maund, Rosalie Nolley, et al. · Laboratory Investigation · 53

PDF

PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers

2022 · Ethan S. Sokol, Dexter X. Jin, et al. · JCO Precision Oncology · 42

PDF

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

2023 · Evelyn Jiagge, Dexter X. Jin, et al. · Cancer Cell · 37

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab

2019 · Luciana Molinero, Yijin Li, et al. · Journal for ImmunoTherapy of Cancer · 34

PDF

Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy

2013 · Brian Belardi, Adam de la Zerda, et al. · Angewandte Chemie · 26

Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations

2022 · Jessica W. Chen, Karthikeyan Murugesan, et al. · JCO Precision Oncology · 25

PDF

Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors

2022 · Derrek P. Hibar, George D. Demetri, et al. · PLoS ONE · 22

PDF

A Role for Interleukin-1 Alpha in the 1,25 Dihydroxyvitamin D3 Response in Mammary Epithelial Cells

2013 · Sophia L. Maund, Lihong Shi, et al. · PLoS ONE · 18

PDF

NTRK gene fusions are detected in both secretory and non‐secretory breast cancers

2022 · Sophia L. Maund, Ethan S. Sokol, et al. · Pathology International · 17

The Tissue-Specific Stem Cell as a Target for Chemoprevention

2010 · Sophia L. Maund, Scott D. Cramer · Stem Cell Reviews and Reports · 16

Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers

2024 · Ruishan Liu, Shemra Rizzo, et al. · Nature Communications · 14

PDF

A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer

2023 · David Pook, Daniel M. Geynisman, et al. · Clinical Cancer Research · 12

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

2021 · C. B. Westphalen, M. G. Krebs, et al. · npj Precision Oncology · 8

PDF

Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents

2025 · Anne C. Chiang, Russell W. Madison, et al. · JTO Clinical and Research Reports · 7

PDF

Genomic characteristics and predicted ancestry of NTRK1/2/3 and ROS1 fusion-positive tumours from >165,000 pan-solid tumours

2019 · T.R. Wilson, E.S. Sokol, et al. · Annals of Oncology · 6

PDF

Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC

2024 · Yichen Lu, Spencer S. Langerman, et al. · JAMA Network Open · 5

Works count: 78

Citation count: 1,485

H-index: 17

I10-index: 21